Evidence map›Paper›PMID 38888774›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Median Tissue Culture Infectious Dose 50 (TCID

Kaushal Baid, Kim R Chiok, Arinjay Banerjee

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Isolation, Passage, and Pathogenicity of a Newly IsolatedTransboundary and emerging diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kaushal BaidVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
Kim R ChiokVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
Arinjay BanerjeeVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada. arinjay.banerjee@usask.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of zoonotic viruses like severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2 have significantly impacted global health and economy. The discovery of other viruses in wildlife reservoir species present a threat for future emergence in humans and animals. Therefore, assays that are less reliant on virus-specific information, such as neutralization assays, are crucial to rapidly develop diagnostics, understand virus replication and pathogenicity, and assess the efficacy of therapeutics against newly emerging viruses. Here, we describe the discontinuous median tissue culture infectious dose 50 (TCID

Indexed as

Cytopathogenic Effect, ViralAnimalsChlorocebus aethiopsCOVID-19HumansSARS-CoV-2Tissue Culture TechniquesVero CellsVirus ReplicationBiosafety level 3Cytopathic effectEndpoint dilutionPermissive cell lineRisk group 3 pathogenTiterVirus infectivity

Identifiers

PMID38888774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.